Skip to main content
Caplight Logo









Shanghai Umibio Biotechnology Co., Ltd.

Shanghai Umibio Biotechnology Co., Ltd.

Private
ShanghaiHealthcare & Life Scienceshttps://umibio.cn/

Last Round

Series B

Extension

Mar 30, 2021

Total Funding Raised

$27.01M

Company Overview

Shanghai Umibio Biotechnology Co., Ltd. is a biotechnology company that provides exosome research, services, and related reagent development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

exosome isolationexosome purificationexosome researchexosome extraction kitextracellular vesiclesEV researchserum-free culture mediabiotechnology reagentscell culture mediaexosome labelinglife science toolsdrug delivery researchregenerative medicinelab reagentsbiotech supply

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanghai Umibio Biotechnology Co., Ltd. Comparables

Compare Shanghai Umibio Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.

Shanghai Umibio Biotechnology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Carrier Biomed (Suzhou) Co., Ltd.
86%
CellBio Scientific
80%
Izon Science
78%

Shanghai Umibio Biotechnology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionMar 30, 2021
Series AOct 19, 2018
AngelMar 1, 2016

Shanghai Umibio Biotechnology Co., Ltd. Investors

Notable investors and investment history

Shanghai Umibio Biotechnology Co., Ltd. investors
InvestorRounds
Alwin CapitalSeries A
Apricot CapitalAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 30, 2021

    Raised $4.61M in a Series B Extension round.

  • Oct 19, 2018

    $7.2M round with Alwin Capital and Hainan Haiyao Co Ltd.

Shanghai Umibio Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Shanghai Umibio Biotechnology Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shanghai Umibio Biotechnology Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai
Employee Range-
Year Founded2015
Last FundingMar 30, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?